L-Tryptophan

Alternative Medicine Review

Volumn 11, Issue 1, 2006, Pages 52-56

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN;

AUTOIMMUNE DISEASE; BLOOD BRAIN BARRIER; DEPRESSION; DIET SUPPLEMENTATION; DRUG MARKETING; ENZYME ACTIVITY; ENZYME INHIBITION; EOSINOPHILIA MYALGIA SYNDROME; HEAD TWITCH; HUMAN; MENTAL DISEASE; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PYRIDOXINE DEFICIENCY; REVIEW; SEASONAL AFFECTIVE DISORDER; SEROTONIN SYNDROME; SLEEP DISORDER; SMOKING; SMOKING CESSATION; STOMACH IRRITATION; TRYPTOPHAN METABOLISM; VOMITING;

EID: 33645790456     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. nd ed. Portland, OR: Omni-Press; 1999:95-98.
2. nd ed. New York, NY: Saunders; 2003:94-104.
3. Kilbourne EM, Philen RM, Kamb ML, Falk H. Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome. J Rheumatol Suppl 1996;46:81-88.
4. Hussain AM, Mitra AK. Effect of aging on tryptophan hydroxylase in rat brain: implications on serotonin level. Drug Metab Dispos 2000;28:1038-1042.
5. Caballero B, Finer N, Wurtman RJ. Plasma amino acids and insulin levels in obesity: response to carbohydrate intake and tryptophan supplements. Metabolism 1988;37:672-676.
6. van Praag HM. Management of depression with serotonin precursors. Biol Psychiatry 1981;16:291-310.
7. Lucini V, Lucca A, Catalano M, Smeraldi E. Predictive value of tryptophan/large neutral amino acids ratio to antidepressant response. J Affect Disord 1996;36:129-133.
8. Lieberman HR, Caballero B, Finer N. The composition of lunch determines afternoon plasma tryptophan ratios in humans. J Neural Transm 1986;65:211-217.
9. Zammarchi E, La Rosa S, Pierro U, et al. Free tryptophan decrease in jaundiced newborn infants during phototherapy. Biol Neonate 1989;55:224-227.
10. Blomstrand E, Celsing F, Newsholme EA. Changes in plasma concentrations of aromatic and branched-chain amino acids during sustained exercise in man and their possible role in fatigue. Acta Physiol Scand 1988;133:115-121.
11. Zimmermann M. Burgerstein's Handbook of Nutrition. New York, NY: Thieme; 2001:109-111.
12. nd ed. Portland, OR: Omni-Press; 1999:200-205.
13. van Praag HM, Lemus C. Monoamine precursors in the treatment of psychiatric disorders. In: Wurtman RJ, Wurtman JJ, eds. Nutrition and the Brain. New York, NY: Raven Press; 1986:89-139.
14. den Boer JA, Westenberg HG. Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder. Psychiatry Res 1990;31:267-278.
15. Chadwick D, Jenner P, Harris R, et al. Manipulation of brain serotonin in the treatment of myoclonus. Lancet 1975;2:434-435.
16. Guilleminault C, Tharp BR, Cousin D. HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements. J Neurol Sci 1973;18:435-441.
17. Maes M, Vandevelde R, Suy E. Influences on cortisol and noradrenergic turnover of healthy controls and depressed patients during L-tryptophan loading. J Affect Disord 1989;17:173-182.
18. Maes M, Schotte C, Scharpe S, et al. The effects of glucocorticoids on the availability of L-tryptophan and tyrosine in the plasma of depressed patients. J Affect Disord 1990;18:121-127.
19. Traskman-Bendz L, Haskett RF, Zis AP Neuroendocrine effects of L-tryptophan and dexamethasone. Psychopharmacology (Berl) 1986;89:85-88.
20. Winokur A, Lindberg ND, Lucki I, et al. Hormonal and behavioral effects associated with intravenous L-tryptophan administration. Psychopharmacology (Berl) 1986;88:213-219.
21. Steinberg S, Annable L, Young SN, Liyanage N. A placebo-controlled study of the effects of L-tryptophan in patients with premenstrual dysphoria. Adv Exp Med Biol 1999;467:85-88.
22. Hrboticky N, Leiter LA, Anderson GH. Menstrual cycle effects on the metabolism of tryptophan loads. Am J Clin Nutr 1989;50:46-52.
23. Ghadirian AM, Murphy BE, Gendron MJ. Efficacy of light versus tryptophan therapy in seasonal affective disorder. J Affect Disord 1998;50:23-27.
24. McGrath RE, Buckwald B, Resnick EV. The effect of L-tryptophan on seasonal affective disorder. J Clin Psychiatry 1990;51:162-163.
25. Schneider-Helmert D, Spinweber CL. Evaluation of L-tryptophan for treatment of insomnia: a review. Psychopharmacology (Berl) 1986;89:1-7.
26. Korner E, Bertha G, Flooh E, et al. Sleep-inducing effect of L-tryptophane. Eur Neurol 1986;25:75-81.
27. Hartmann E, Spinweber CL. Sleep induced by L-tryptophan. Effect of dosages within the normal dietary intake. J Nerv Ment Dis 1979;167:497-499.
28. Schmidt HS. L-tryptophan in the treatment of impaired respiration in sleep. Bull Eur Physiopathol Respir 1983;19:625-629.
29. Lieberman HR, Corkin S, Spring BJ, et al. The effects of dietary neurotransmitter precursors on human behavior. Am J Clin Nutr 1985;42:366-370.
30. van Praag H, de Kann S. Depression vulnerability and 5-hydroxytryptophan prophylaxis. Psychiatry Res 1980;3:75-83.
31. Loo H, Zarifian E, Wirth JF, Deniker P. Open study of L-5-H.T.P. in melancholic depressed patients over 50 years of age. Encephale 1980;6:241-246. [Article in French]
32. van Hiele LJ. L-5-Hydroxytryptophan in depression: the first substitution therapy in psychiatry? The treatment of 99 out-patients with "therapy-resistant" depressions. Neuropsychobiology 1980;6:230-240.
33. Angst J, Woggon B, Schoepf J. The treatment of depression with L-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study. Arch Psychiatr Nervenkr 1977;224:175-186.
34. Alino JJ, Gutierrez JL, Iglesias ML. 5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressions. A double-blind controlled study. Int Pharmacopsychiatry 1976;11:8-15.
35. Takahashi S, Kondo H, Kato N. Effect of L-5-hydroxytryptophan on brain monoamine metabolism and evaluation of its clinical effect in depressed patients. J Psychiatr Res 1975;12:177-187.
36. Persson T, Roos BE. 5-hydroxytryptophan for depression. Lancet 1967;2:987-988.
37. Cowen PJ, Parry-Billings M, Newsholme EA. Decreased plasma tryptophan levels in major depression. J Affect Disord 1989;16:27-31.
38. Bell C, Abrams J, Nutt D. Tryptophan depletion and its implications for psychiatry. Br J Psychiatry 2001;178:399-405.
39. Murphy FC, Smith KA, Cowen PJ, et al. The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology (Berl) 2002;163:42-53.
40. Evers EA, Tillie DE, van der Veen FM, et al. Effects of a novel method of acute tryptophan depletion on plasma tryptophan and cognitive performance in healthy volunteers. Psychopharmacology (Berl) 2005;178:92-99.
41. Clark L, Roiser JP, Cools R, et al. Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology (Berl) 2005;182:570-578.
42. Praschak-Rieder N, Wilson AA, Hussey D, et al. Effects of tryptophan depletion on the serotonin transporter in healthy humans. Biol Psychiatry 2005;58:825-830.
43. Smith KA, Fairburn CG, Cowen PJ. Symptomatic relapse in bulimia nervosa following acute tryptophan depletion. Arch Gen Psychiatry 1999;56:171-176.
44. Sharma RP, Shapiro LE, Kamath SK, et al. Acute dietary tryptophan depletion: effects on schizophrenic positive and negative symptoms. Neuropsychobiology 1997;35:5-10.
45. Joyce PR, Porter RJ, Mulder RT, et al. Reversed diurnal variation in depression: associations with a differential antidepressant response, tryptophan: large neutral amino acid ratio and serotonin transporter polymorphisms. Psychol Med 2005;35:511-517.
46. Bowen DJ, Spring B, Fox E. Tryptophan and high-carbohydrate diets as adjuncts to smoking cessation therapy. J Behav Med 1991;14:97-110.
47. nd ed. New York, NY: Churchhill Livingstone; 1999:225-228.
48. Bonney EA, Matzinger P. Much IDO about pregnancy. Nat Med 1998;4:1128-1129.
49. Bender DA. Non-nutritional uses of vitamin B6. Br J Nutr 1999;81:7-20.
50. Roberts JE, Wishart JF, Martinez L, Chignell CF. Photochemical studies on xanthurenic acid. Photochem Photobiol 2000;72:467-471.
51. Price WA, Zimmer B, Kucas P. Serotonin syndrome: a case report. J Clin Pharmacol 1986;26:77-78.
52. Baloh RW, Dietz J, Spooner JW Myoclonus and ocular oscillations induced by L-tryptophan. Ann Neurol 1982;11:95-97.
53. Rossle M, Herz R, Klein B, Gerok W. Tryptophan metabolism in liver diseases: a pharmacokinetic and enzymatic study. Klin Wochenschr 1986;64:590-594. [Article in German]
54. Devoe LD, Castillo RA, Searle NS, Searle JR. Maternal dietary substrates and human fetal biophysical activity. I. The effects of tryptophan and glucose on fetal breathing movements. Am J Obstet Gynecol 1986;155:135-139.